New HTAIS Video

Presentation Title ¬	Date Posted ¬	Links ¬	Size ¬
FDA Circulatory Systems Devices Panel for Drug-Eluting Stents (Part 1) — Introduction & Background (Length: 9 minutes)	12/20/2006		4MB
FDA Circulatory Systems Devices Panel for Drug-Eluting Stents (Part 2) — On-Label Indications (Length: 18 minutes)	12/20/2006		8MB
FDA Circulatory Systems Devices Panel for Drug-Eluting Stents (Part 3) — Off-Label Uses (Length: 22 minutes)	12/20/2006		9MB

Download Dr. Reston's Presentation (PDF)
As debate continues over concerns about late-occurring thrombosis associated with drug-eluting stent implantation and the optimal duration of dual-antiplatelet therapy, ECRI is pleased to provide expert analysis of important highlights from the recent U.S. Food and Drug Administration advisory panel that convened December 7 and 8, 2006 to view data and hear presentations on these issues. Click here to download ECRI's PDF slideshow by ECRI Senior Research Analyst James Reston, PhD, MPH.

Additional Coverage by ECRI's Health Technology Trends Newsletter (PDF)
ECRI's Health Technology Trends newsletter provides expert analysis of the important highlights from the recent U.S. Food and Drug Administration advisory panel that convened to view data and hear presentations on late stent thrombosis associated with drug-eluting stents. Click here to read the Trends article in PDF.

About Streaming Video
These presentations can be viewed using Microsoft Windows Media Player. For more information or to download the media player, click here.

Terms of Use
This presentation is for informational and educational purposes.  The content may not be republished, reproduced, transmitted, or distributed, whether mechanically, electronically, or in any other medium, without prior approval of the copyright holders. Commercial reproduction and multiple distribution or publication, in any form or medium, are expressly prohibited.